financetom
Market
financetom
/
Market
/
Focus on frontline banking stocks; be cautious on retail lending NBFCs: BNP Paribas
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Focus on frontline banking stocks; be cautious on retail lending NBFCs: BNP Paribas
Jul 5, 2021 3:35 AM

BNP Paribas will continue to focus on frontline banking stocks, Manishi Raychaudhuri, Asian equity strategist, equity cash Asia Pacific, told CNBC-TV18.

“I would still stick to the largecap frontline private sector banks because they have demonstrated their ability to gain market share and have a better asset quality, both in corporate lending and retail lending compared to their public sector counterparts and non-banking financial companies (NBFCs),” he said.

“The area that I would be slightly concerned about at this point of time are some of the pure retail lending NBFCs,” said Raychaudhuri.

When asked about his picks in the Indian markets, whether he would have an economy-facing or defensive strategy, he said “We have feet in two boat kind of strategy.” He further explained, “Possibly, it’s a value which offers more opportunities now, simply because the difference in valuation and the difference in ownership from institutions and retail’s perspective had become too large a gap between growth and value. Some of the classic value plays like the public sector banks are also starting to do well even though they may lose market share in the long-term, but it seems in the medium term, they have built a significant credit cost buffer. That could potentially lead to an earnings growth story over the next couple of years.”

On equity markets, he said, “We think regional markets including India will continue to remain strong for a while. It is clear from various central banks’ pronouncements over the past few days that they are not likely to step away from this accelerator on easy monetary policy and quantitative expansion that they are doing.”

For the entire interview, watch the video.

(Edited by : Dipika Ghosh)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Tech
Sector Update: Tech
Dec 9, 2024
03:27 PM EST, 12/09/2024 (MT Newswires) -- Tech stocks were mixed late Monday afternoon, with the Technology Select Sector SPDR Fund (XLK) decreasing 0.8% and the SPDR S&P Semiconductor ETF (XSD) rising 0.4%. The Philadelphia Semiconductor index fell 1%. In corporate news, VeriSign ( VRSN ) shares jumped 5.2% after Baird upgraded the company's stock to outperform from neutral, while...
Sector Update: Energy
Sector Update: Energy
Dec 9, 2024
03:21 PM EST, 12/09/2024 (MT Newswires) -- Energy stocks rose late Monday afternoon with the NYSE Energy Sector Index adding 0.6% and the Energy Select Sector SPDR Fund (XLE) up 0.3%. The Philadelphia Oil Service Sector index climbed 1.1%, and the Dow Jones US Utilities index shed 1.3%. West Texas Intermediate crude oil rose 1.6% to $68.29 a barrel, while...
Sector Update: Financial
Sector Update: Financial
Dec 9, 2024
03:21 PM EST, 12/09/2024 (MT Newswires) -- Financial stocks fell late Monday afternoon trading, with the NYSE Financial Index down 0.7% and the Financial Select Sector SPDR Fund (XLF) shedding 1.1%. The Philadelphia Housing Index was fractionally lower, and the Real Estate Select Sector SPDR Fund (XLRE) was up 0.2%. Bitcoin (BTC-USD) fell 4.1% to $97,023, and the yield for...
Sector Update: Health Care
Sector Update: Health Care
Dec 9, 2024
03:32 PM EST, 12/09/2024 (MT Newswires) -- Health care stocks rose late Monday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both up 0.3%. The iShares Biotechnology ETF (IBB) rose 0.5%. In corporate news, GSK (GSK) shares climbed 4.6%. The company said a phase 3 trial showed a statistically significant and clinically...
Copyright 2023-2025 - www.financetom.com All Rights Reserved